Meet In CommonNewsRSS feeds

Local

Molly Carberry sings ragged rock odes to her ups and downs on The Year I Went Blind

A Roundtable is a way to meet new people and discuss this article in person at a local coffee shop or other venue.

Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.

Source: Chicago Reader

Molly Carberry Credit: Malcolm Riordan Chicago singer-songwriter Molly Carberry spontaneously went blind in one eye a few years ago. She poured her anger, sadness, grief, and frustration—toward her body, toward herself, toward the world—into the snarling grunge riffs of “The Hope I Dread,” a single from her new debut EP, The Year I Went Blind. She was diagnosed with lupus in 2023, but she sings as if she’s still in the throes of an illness that’s doubly terrifying for being unknown. The lo-fi grittiness of “The Hope I Dread” is a constant throughout The Year I Went Blind, so that Carberry often sounds like she’s just run onstage, ready to rip through her songs without a sound check. She recruited seven other musicians to flesh out her EP: a second guitarist, a rock rhythm section, and four string players (including indie workhorse Chaepter Negro on cello) who appear on two tracks.

This excerpt comes from the named source. Read the original for the full reporting.

Read the original at Chicago Reader

Featured places to meet in Palo Alto, CA

Explore these places and arrange a conversation through ThinkMatch.

City guide for Palo Alto, CA

Community Poll

Improving employee pay should take priority over increasing shareholder payouts.

Share your view, then see how readers voted. No sign-in required. This poll is shared across stories.

Do you agree or disagree?

Choose one answer

Common Quandary

A Common Quandary to discuss

Another conversation to explore, separate from this news story.

Scientists can edit mosquitoes until a deadly disease disappears. Who gets to say yes?

Scientists can potentially release modified mosquitoes whose genes would spread through wild populations and sharply reduce a deadly disease. The ecological effects could cross borders and may be impossible to reverse.

Who may authorize an irreversible change intended to save lives?

Explore this quandary